NFKB1 and breast cancer: In particular, we selected SKBR3 cells, an ER-negative and HER-2+ breast cancer model system, featured by increased NF-κB signaling activity28 in which we recently found an upregulation of KCTD15 (Smaldone et al. under review) (see also Supplementary Figure 4).